Technical topics at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

15 organizations at AMP 2026 present work in technical topics: 12 academic medical centres, children's hospitals and universities, 1 public organization, 1 company and 1 clinical laboratory. Between them they bring 66 presentations to the program. Most represented: MD Anderson Cancer Center (9 on the program), Palmetto GBA (8 on the program), University of Michigan (6 on the program). 15 of them have their own page in this guide. As of Sep 25, 2026.

All 298 organizations at AMP 2026 →

Showing 1–7 of 15 organizations

Organization	AMP 2026 Attendance
MD Anderson Cancer Center Houston, TX
mdanderson.org Med centres Comprehensive cancer center and academic medical institution in Houston, with clinical molecular diagnostics laboratories.	Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Workshop hosted by Thermo Fisher Scientific Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. Workshop hosted by Countable Labs Tahoma 2, Level 3, Arch at 800 Pike Workshop Wed, Nov 11 2:00pm–2:50pm Unlocking AML Biology with 5-Base Whole-Genome Sequencing: Integrated Genomic and Epigenomic Profiling for Biomarker Discovery Five-base whole-genome sequencing reads methylation and genomic variation from one AML sample to find research biomarkers. Workshop hosted by Illumina Skagit 1, Lower Level, Arch at 800 Pike Session Thu, Nov 12 10:15am–11:45am Clinical Applications of Transcriptomics in Lymphomas and Leukemias 608-609, Level 6, Arch at 705 Pike Hematopathology 10:15am–10:45amLong-Read Transcriptome Sequencing Enables Accessible Molecular Diagnostics for Pediatric LeukemiaUniversity of North Carolina at Chapel Hill 10:45am–11:15amNew Insights from Gene Expression Profiling of Anaplastic Large Cell LymphomaMayo Clinic Workshop Thu, Nov 12 12:00pm–12:30pm AMP Practice Guidelines Meet the Authors Series: Lung Guideline Update New lung cancer molecular testing recommendations from the updated joint practice guideline, with the evidence and process behind them. Innovation Spotlight Stage #2 Session Fri, Nov 13 10:15am–11:45am Accelerating the Impact of Molecular Profiling in Pediatric and Adolescent Young Adult (AYA) Tumors Ballroom E, Level 6, Arch at 705 Pike Hematopathology · Solid Tumors 10:15am–11:00amFrom Profiling to Clinical Impact: Advancing Molecular Diagnostics for Pediatric and AYA CancersBoston Children's Hospital/ Dana Farber Cancer Institute 11:00am–11:45amPresentation Title TBD Session Fri, Nov 13 1:15pm–2:45pm Menin Inhibitors and Targeted Therapy Resistance in AML 608-609, Level 6, Arch at 705 Pike Hematopathology 1:15pm–2:00pmMenin Inhibitor Use in Acute Myeloid LeukemiaJohns Hopkins 2:00pm–2:45pmDevelopment and Use of Menin Inhibitors as Precision Medicines for Acute Myeloid LeukemiaUniversity of Michigan Workshop Fri, Nov 13 9:30am–10:00am Electronic Genome Mapping for Structural Variant Detection: Implications for Advancing Clinical Research in Heme Malignancies Electronic genome mapping weighed against karyotyping, FISH and optical mapping for structural variants, including marrow versus blood samples. Workshop hosted by Nabsys Innovation Spotlight Stage #1 Talk Sat, Nov 14 10:15am–11:00am Part of Foundation Models in Molecular From AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing? How well DNA foundation models actually perform on clinical genomic tasks, and how to judge which ones to trust. 608-609, Level 6, Arch at 705 Pike Informatics Talk Sat, Nov 14 10:15am–11:00am Part of Update on the Role of CtDNA-Based Detection of MRD in Clinical Trials and Beyond for Solid Tumors Minimal Residual Disease in Colorectal Cancer: Opportunities for therapeutic development Ballroom E, Level 6, Arch at 705 Pike Solid Tumors Poster Sat, Nov 14 1:45pm–2:00pm Part of Platform Presentations of Selected HemePath Abstracts II H078 Clinical Significance of Clonal Hematopoiesis Detected by Paired Plasma and Peripheral Blood Liquid Biopsy Testing in Patients with Solid Tumors 606-607, Level 6, Arch at 705 Pike Session Sat, Nov 14 2:30pm–4:00pm Technical Advances in Molecular Measurable Residual Disease Detection in Hematologic Neoplasms 611-614, Level 6, Arch at 705 Pike Hematopathology · Technical Topics 2:30pm–2:45pmMeasurable Residual Disease Testing in Acute Myeloid Leukemia: Moving From Theory to PracticeVirginia Tech 2:45pm–4:00pmToward a Paradigm Shift in Personalized Therapies for Lymphoma Using Liquid BiopsiesStanford University Talk Sat, Nov 14 3:00pm–3:30pm Part of Technical Advancement in Methylation Profiling Direct DNA Methylation Analysis by Single Molecule Real-Time Sequencing A transformer model reads polymerase kinetics from SMRT sequencing to call 5mC, 5hmC and 6mA base modifications directly. 608-609, Level 6, Arch at 705 Pike Technical Topics
Palmetto GBA Columbia, SC
palmettogba.com Gov/NGO Medicare Administrative Contractor that runs the MolDX program, setting coverage and reimbursement policy for molecular diagnostic tests.	Session Thu, Nov 12 10:15am–11:45am Technical Advancement in Spatial Genomics and Multi-omics 602-604, Level 6, Arch at 705 Pike Solid Tumors 10:15am–11:00amSpatial Multi-Omics Profiling in TissuesUniversity of Pennsylvania 11:00am–11:45amMolecular-Resolution Spatial Inference of Subcellular Transcriptional ProgramsUniversity of Michigan Session Fri, Nov 13 10:15am–11:45am Technologist Innovation Session 602-604, Level 6, Arch at 705 Pike Technical Topics 10:15am–10:35amTT009 Assessment of X-Chromosome Inactivation Using Oxford Nanopore Technologies (ONT) Long-Read SequencingMayo Clinic 10:35am–10:55amID024 Evaluation of a Targeted Metagenomics Kit for Microbial Identification Using the V1-V2 Region of the 16S Ribosomal RNA GeneMayo Clinic 10:55am–11:15amG010 Comparison of Manual Illumina PCR-Free and Hamilton NGS STAR Automated Library Preparation for Germline Whole Genome SequencingToronto General Hospital 11:15am–11:35amH010 Laboratory Developed Test Validation of FL24Cx: A Gene Expression Profiling Assay to Predict Risk of Early Events in Follicular LymphomaUniversity of Arizona Session Fri, Nov 13 3:45pm–4:45pm Technical Topics Plenary Session Ballroom ABC, Level 6, Arch at 705 Pike Technical Topics 3:45pm–4:45pmStepping Towards Single-Molecule Protein Sequencing Using NanoporesUniversity of Washington Session Sat, Nov 14 2:30pm–4:00pm Technical Advances in Molecular Measurable Residual Disease Detection in Hematologic Neoplasms 611-614, Level 6, Arch at 705 Pike Hematopathology · Technical Topics 2:30pm–2:45pmMeasurable Residual Disease Testing in Acute Myeloid Leukemia: Moving From Theory to PracticeVirginia Tech 2:45pm–4:00pmToward a Paradigm Shift in Personalized Therapies for Lymphoma Using Liquid BiopsiesStanford University
University of Michigan Ann Arbor, MI
umich.edu Med centres Public research university and academic medical centre in Ann Arbor with clinical cancer genomics and molecular diagnostics programmes.	Session Thu, Nov 12 10:15am–11:45am Clinical Applications of Transcriptomics in Lymphomas and Leukemias 608-609, Level 6, Arch at 705 Pike Hematopathology 10:15am–10:45amLong-Read Transcriptome Sequencing Enables Accessible Molecular Diagnostics for Pediatric LeukemiaUniversity of North Carolina at Chapel Hill 10:45am–11:15amNew Insights from Gene Expression Profiling of Anaplastic Large Cell LymphomaMayo Clinic Session Thu, Nov 12 10:15am–11:45am Technical Advancement in Spatial Genomics and Multi-omics 602-604, Level 6, Arch at 705 Pike Solid Tumors 10:15am–11:00amSpatial Multi-Omics Profiling in TissuesUniversity of Pennsylvania 11:00am–11:45amMolecular-Resolution Spatial Inference of Subcellular Transcriptional ProgramsUniversity of Michigan Talk Thu, Nov 12 11:00am–11:45am Part of Technical Advancement in Spatial Genomics and Multi-omics Molecular-Resolution Spatial Inference of Subcellular Transcriptional Programs Submicron spatial transcriptomics plus segmentation-free analysis that assigns cell type and transcriptional programs from individual transcripts. 602-604, Level 6, Arch at 705 Pike Technical Topics Workshop Thu, Nov 12 12:40pm–1:10pm AI in Trainee Education: A Demonstration and Discussion Building a large language model study aid for pathology trainees, alongside survey findings on how trainees and educators use AI. Innovation Spotlight Stage #3 Talk Thu, Nov 12 8:30am–8:45am Opening Remarks Ballroom ABC, Level 6, Arch at 705 Pike 8:30am–8:45amOpening Remarks Talk Fri, Nov 13 2:00pm–2:45pm Part of Menin Inhibitors and Targeted Therapy Resistance in AML Development and Use of Menin Inhibitors as Precision Medicines for Acute Myeloid Leukemia Development of menin inhibitors for KMT2A-rearranged and NPM1-mutant acute myeloid leukemia, plus response biomarkers and resistance. 608-609, Level 6, Arch at 705 Pike Hematopathology Poster Fri, Nov 13 7:15am–7:30am Part of Platform Presentations of Selected HemePath Abstracts I H069 Using Optical Genome Mapping in Standard-of-care of Acute Leukemias: 7 Months’ Clinical Experience
University of Washington Seattle, WA
washington.edu Med centres Public research university in Seattle with a genome sciences department and clinical laboratories in genetics and laboratory medicine.	Workshop Wed, Nov 11 2:00pm–3:50pm Evaluation of the BioCode® STI + Resistance Panel for STI Detection, Antimicrobial Resistance Markers, and Multiplex STI Panels Reimbursement Considerations Performance of a multiplex panel detecting chlamydia, gonorrhea, mycoplasma and trichomonas with resistance markers, plus reimbursement. Workshop hosted by Applied BioCode Skagit 4, Lower Level, Arch at 800 Pike Talk Thu, Nov 12 2:30pm–3:00pm Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting AMP Clinical Validation of cfDNA and ctDNA Assays Working Group Setting validation standards for liquid biopsy assays in oncology, with attendee input shaping the guideline under development. Ballroom E, Level 6, Arch at 705 Pike Session Thu, Nov 12 2:30pm–3:30pm Platform Presentations of Selected Informatics Abstracts I 608-609, Level 6, Arch at 705 Pike 2:30pm–2:45pmI024 A Multimodal Agentic AI Framework for Scalable Variant Curation and Clinical Interpretation of Cancer Whole-Genome SequencingInocras Inc. 2:45pm–3:00pmI053 Predicting Tumor Comprehensive Genomic Profiling Failure from H&E Images 3:00pm–3:15pmI046 Harnessing an Institutional Database of 21 Million Sequences to Optimize Detection of T-Cell Receptor Gamma (TRG) NGS Low-Level Clones Using an Automated Web ApplicationHospital of the University of Pennsylvania 3:15pm–3:30pmI067 Cell‑Free DNA Methylation-Based Fusion Epigenotyping Increases Sensitivity of ALK Fusion Detection in NSCLC Liquid BiopsyGuardant Health Poster Thu, Nov 12 2:45pm–3:00pm Part of Platform Presentations of Selected Infectious Diseases Abstracts ID032 You Found What Where?! Promises and Peril of Plasma Cell-free Metagenomic Sequencing at a Large Medical Center 602-604, Level 6, Arch at 705 Pike Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking More from Every Sample: New Multiplex Oncology Assays and Emerging MRD Applications with the QX700™ ddPCR™ System Multiplexed droplet digital PCR assays that pull more oncology biomarker data from limited samples, including residual disease monitoring. Workshop hosted by Bio-Rad Laboratories Innovation Spotlight Stage #2 Talk Fri, Nov 13 1:15pm–2:45pm Part of Optimizing Computational Infrastructure for High-throughput Clinical Data Beyond Git: Bringing CI/CD to Clinical Bioinformatics How Git version control and CI/CD pipelines make clinical bioinformatics software reproducible, traceable and ready for regulatory review. 611-614, Level 6, Arch at 705 Pike Informatics Plenary Fri, Nov 13 3:45pm–4:45pm Part of Technical Topics Plenary Session Stepping Towards Single-Molecule Protein Sequencing Using Nanopores Ballroom ABC, Level 6, Arch at 705 Pike Technical Topics Talk Sat, Nov 14 2:30pm–3:15pm Part of Advances in STI Testing Through the Years Beyond the Swab: The Evolution of STI Diagnostics Sexually transmitted infection testing from culture-era methods to multiplex and point-of-care molecular assays, and what comes next. 602-604, Level 6, Arch at 705 Pike Infectious Diseases Poster Sat, Nov 14 7:45am–8:00am Part of Platform Presentations of Selected Solid Tumors Abstracts I ST161 Genome-Wide Detection of Structural Variants and Copy Number Aberrations in Unclassified Sarcomas Using Hi-C Based Genomic Proximity Mapping
Stanford University Stanford, CA
stanford.edu Med centres Private research university in California whose medical school runs clinical genomics, molecular pathology and metagenomic sequencing laboratories.	Session Thu, Nov 12 10:15am–11:45am Clinically Actionable Mutational Signatures in Solid Tumors Ballroom E, Level 6, Arch at 705 Pike Solid Tumors 10:15am–10:45amDetecting Homologous Recombination Deficiency with Genomic and AI-Based ApproachesUniversity of California San Diego 10:45am–11:15amClinical Utility of Detecting Mismatch Repair Deficiency as a Mutational SignatureBrigham and Women's Hospital 11:15am–11:45amNovel Mutational Signatures in CancerUniversity of California San Francisco Talk Thu, Nov 12 11:00am–11:45am Part of Computational Analysis of Fragmentation and Methylation Patterns in ctDNA for Early Cancer Detection Multi-Omic Single Molecule Profiling of Cell Free DNA Reveals Cancer Signatures Single-molecule reads of scant cell-free DNA capture methylation, hydroxymethylation and fragmentation to profile cancers and spot brain metastases. 611-614, Level 6, Arch at 705 Pike Informatics Session Thu, Nov 12 1:15pm–2:15pm Solid Tumors Plenary Session Ballroom ABC, Level 6, Arch at 705 Pike Solid Tumors 1:15pm–2:15pmDNA Methylation and Artificial Intelligence for the Diagnosis and Classification of CNS TumorsMayo Clinic Session Fri, Nov 13 10:15am–11:45am Clinical Metagenomic NGS for Infectious Disease: Implementation and Interpretation 608-609, Level 6, Arch at 705 Pike Infectious Diseases 10:15am–11:00amNext-Generation Sequencing in the Clinical Microbiology Lab. Use Cases and Justification.Advent Health 11:00am–11:45amInterpreting and reporting respiratory metagenomic tests for the intensive care unitKings College, London Workshop Fri, Nov 13 3:00pm–3:30pm The Practice Pulse: Identifying Where Members Need AMP Most (An AMP Clinical Practice Committee Open Forum) Where clinical practice gaps sit today, with member input steering which problems the committee takes on next. Innovation Spotlight Stage #2 Poster Fri, Nov 13 7:30am–7:45am Part of Platform Presentations of Selected HemePath Abstracts I H068 Real-world Institutional Experience with MassARRAY-based UBA1 Testing for VEXAS Syndrome Session Sat, Nov 14 10:15am–11:45am Current and Emerging Methods for Structural Variants and Gene Fusions 611-614, Level 6, Arch at 705 Pike Hematopathology 10:15am–10:45amFISH vs. RNA sequencing for Structural Variant Detection in Solid Tumors: Strengths and LimitationsMayo Clinic 10:45am–11:15amImplementing Whole Transcriptome Sequencing for Fusion Detection in Solid Tumors: Lessons from the Clinical LaboratoryUniversity of Pittsburgh 11:15am–11:45amProximity Ligation Sequencing (Hi-C) for Oncogene Rearrangements in Lymphoid CancersUniversity of Michigan Medical School Session Sat, Nov 14 1:45pm–2:15pm Part of AMP Clinical Practice Committee Work in Progress Updates - Informatics AMP Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group A working-group update on making genomic variant data interoperable in electronic health records, and where standards still fall short. Talk Sat, Nov 14 2:45pm–4:00pm Part of Technical Advances in Molecular Measurable Residual Disease Detection in Hematologic Neoplasms Toward a Paradigm Shift in Personalized Therapies for Lymphoma Using Liquid Biopsies Circulating tumor DNA in diffuse large B-cell lymphoma for genotyping, early response measurement and residual-disease-guided treatment. 611-614, Level 6, Arch at 705 Pike Hematopathology · Technical Topics
University of Pennsylvania Philadelphia, PA
upenn.edu Med centres Private research university in Philadelphia whose medical school works on genomics, cell therapy and spatial tissue profiling.	Workshop Wed, Nov 11 9:00am–9:50am Agent-Driven variant curation with LLMs and MCP in a Modern LIMS Large language models wired to public variant databases draft tiering suggestions inside a lab system for human review. Workshop hosted by Sectra Yakima 2, Level 1, Arch at 800 Pike Talk Thu, Nov 12 10:15am–11:00am Part of Technical Advancement in Spatial Genomics and Multi-omics Spatial Multi-Omics Profiling in Tissues Spatial multi-omics methods that map RNA, protein and epigenetic marks inside intact tissue, including FFPE and brain samples. 602-604, Level 6, Arch at 705 Pike Technical Topics
Stanford University School of Medicine Stanford, CA
med.stanford.edu Med centres Medical school in California running clinical genomics laboratories, including long-read and whole genome sequencing assays.	Talk Fri, Nov 13 2:15pm–2:45pm Part of Clinical Application of Long-read Sequencing Clinical Implementation of Long-Read Sequencing: From Targeted Assays to Genome Sequencing Bringing long-read sequencing into accredited clinical testing, from single-gene assays through capture panels to whole genomes. Ballroom E, Level 6, Arch at 705 Pike Technical Topics Plenary Fri, Nov 13 8:15am–9:15am Part of Informatics Plenary Session Transforming Healthcare Using Deep Data and Remote Monitoring Multiomics profiling and wearable monitoring of healthy people over 13 years to catch disease before symptoms appear. Ballroom ABC, Level 6, Arch at 705 Pike Informatics